Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Excretion of Orally Administered Corticosteroids
NCT04791345Phase 1Unknown
- Sponsor
- Parc de Salut Mar
- Start
- Feb 2021
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of methylprednisolone, deflazacort and dexamethasone (5 arms), sponsored by Parc de Salut Mar. Primary endpoints: Urine concentration of methylprednisone, Urine concentration of methylprednisone metabolites and 4 more. Status: unknown.
02
Drugs
methylprednisolonedeflazacortdexamethasone
Beyond the preview
Go deeper on NCT04791345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04791345.